J Clin Microbiol. 1993 June; 31(6): 1493-1503
Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.
P Simmonds,
K A Rose,
S Graham,
S W Chan,
F McOmish,
B C Dow,
E A Follett,
P L Yap and
H Marsden
Department of Medical Microbiology, University of Edinburgh, United Kingdom.
ABSTRACT
The effect of sequence variability between different types of hepatitis C virus (HCV) on the antigenicity of the NS-4 protein was investigated by epitope mapping and by enzyme-linked immunosorbent assay with branched oligopeptides. Epitope mapping of the region between amino acid residues 1679 and 1768 in the HCV polyprotein revealed two major antigenic regions (1961 to 1708 and 1710 to 1728) that were recognized by antibody elicited upon natural infection of HCV. The antigenic regions were highly variable between variants of HCV, with only 50 to 60% amino acid sequence similarity between types 1, 2, and 3. Although limited serological cross-reactivity between HCV types was detected between peptides, particularly in the first antigenic region of NS-4, type-specific reactivity formed the principal component of the natural humoral immune response to NS-4. Type-specific antibody to particular HCV types was detected in 89% of the samples from anti-HCV-positive blood donors and correlated almost exactly with genotypic analysis of HCV sequences amplified from the samples by polymerase chain reaction. Whereas almost all blood donors appeared to be infected with a single virus type (97%), a higher proportion of samples (40%) from hemophiliacs infected from transfusion of non-heat-inactivated clotting factor contained antibody to two or even all three HCV types, providing evidence that long-term exposure may lead to multiple infection with different variants of HCV.
J Clin Microbiol. 1993 June; 31(6): 1493-1503
This article has been cited by other articles:
-
Tarr, A. W., Owsianka, A. M., Jayaraj, D., Brown, R. J. P., Hickling, T. P., Irving, W. L., Patel, A. H., Ball, J. K.
(2007). Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33. J. Gen. Virol.
88: 2991-3001
[Abstract]
[Full Text]
-
Bouchardeau, F., Cantaloube, J. F., Chevaliez, S., Portal, C., Razer, A., Lefrere, J.-J., Pawlotsky, J. M., De Micco, P., Laperche, S.
(2007). Improvement of Hepatitis C Virus (HCV) Genotype Determination with the New Version of the INNO-LiPA HCV Assay. J. Clin. Microbiol.
45: 1140-1145
[Abstract]
[Full Text]
-
Sugimoto, K., Kaplan, D. E., Ikeda, F., Ding, J., Schwartz, J., Nunes, F. A., Alter, H. J., Chang, K.-M.
(2005). Strain-Specific T-Cell Suppression and Protective Immunity in Patients with Chronic Hepatitis C Virus Infection. J. Virol.
79: 6976-6983
[Abstract]
[Full Text]
-
Colina, R., Casane, D., Vasquez, S., Garcia-Aguirre, L., Chunga, A., Romero, H., Khan, B., Cristina, J.
(2004). Evidence of intratypic recombination in natural populations of hepatitis C virus. J. Gen. Virol.
85: 31-37
[Abstract]
[Full Text]
-
Kalinina, O., Norder, H., Mukomolov, S., Magnius, L. O.
(2002). A Natural Intergenotypic Recombinant of Hepatitis C Virus Identified in St. Petersburg. J. Virol.
76: 4034-4043
[Abstract]
[Full Text]
-
Dou, X.-G., Talekar, G., Chang, J., Dai, X., Li, L., Bonafonte, M.-T., Holloway, B., Fields, H. A., Khudyakov, Y. E.
(2002). Antigenic Heterogeneity of the Hepatitis C Virus NS5A Protein. J. Clin. Microbiol.
40: 61-67
[Abstract]
[Full Text]
-
Booth, J C L, O'Grady, J, Neuberger, J
(2001). Clinical guidelines on the management of hepatitis C. Gut
49: I1-21
[Full Text]
-
Zein, N. N.
(2000). Clinical Significance of Hepatitis C Virus Genotypes. Clin. Microbiol. Rev.
13: 223-235
[Abstract]
[Full Text]
-
McGuinness, P H, Painter, D, Davies, S, McCaughan, G W
(2000). Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut
46: 260-269
[Abstract]
[Full Text]
-
ZEKRI, A.-R. N., BAHNASSY, A. A., SHAARAWY, S. M., MANSOUR, O. A., MADUAR, M. A., KHALED, H. M., EL-AHMADI, O.
(2000). Hepatitis C virus genotyping in relation to neu-oncoprotein overexpression and the development of hepatocellular carcinoma. J Med Microbiol
49: 89-95
[Abstract]
[Full Text]
-
Schröter, M., Feucht, H.-H., Schäfer, P., Zöllner, B., Laufs, R.
(1999). Serological Determination of Hepatitis C Virus Subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a Recombinant Immunoblot Assay. J. Clin. Microbiol.
37: 2576-2580
[Abstract]
[Full Text]
-
Chien, D. Y., Arcangel, P., Medina-Selby, A., Coit, D., Baumeister, M., Nguyen, S., George-Nascimento, C., Gyenes, A., Kuo, G., Valenzuela, P.
(1999). Use of a Novel Hepatitis C Virus (HCV) Major-Epitope Chimeric Polypeptide for Diagnosis of HCV Infection. J. Clin. Microbiol.
37: 1393-1397
[Abstract]
[Full Text]
-
Rodriguez-Lopez, M, Riezu-Boj, J., Ruiz, M, Berasain, C, Civeira, M., Prieto, J, Borras-Cuesta, F
(1999). Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA. J. Gen. Virol.
80: 727-738
[Abstract]
-
Wong, J. B., Bennett, W. G., Koff, R. S., Pauker, S. G.
(1998). Pretreatment Evaluation of Chronic Hepatitis C: Risks, Benefits, and Costs. JAMA
280: 2088-2093
[Abstract]
[Full Text]
-
Muir, P., Kammerer, U., Korn, K., Mulders, M. N., Poyry, T., Weissbrich, B., Kandolf, R., Cleator, G. M., van Loon, A. M.
(1998). Molecular Typing of Enteroviruses: Current Status and Future Requirements. Clin. Microbiol. Rev.
11: 202-227
[Abstract]
[Full Text]
-
Irving, W L, Neal, K R, Underwood, J C E, Simmonds, P N, James, V
(1994). Chronic hepatitis in United Kingdom blood donors infected with hepatitis C virus. BMJ
308: 695-696
[Full Text]
-
Chemello, L., Alberti, A., Rose, K., Simmonds, P.
(1994). Hepatitis C Serotype and Response to Interferon Therapy. NEJM
330: 143-143
[Full Text]
Copyright © 1993 by the American Society for Microbiology. All rights reserved.